Cargando…
Osteolytic effects of tumoral estrogen signaling in an estrogen receptor-positive breast cancer bone metastasis model
AIM: Estrogen receptor α-positive (ER+) subtypes of breast cancer have the greatest predilection for forming osteolytic bone metastases (BMETs). Because tumor-derived factors mediate osteolysis, a possible role for tumoral ERα signaling in driving ER+ BMET osteolysis was queried using an estrogen (E...
Autores principales: | Cheng, Julia N., Frye, Jennifer B., Whitman, Susan A., Kunihiro, Andrew G., Brickey, Julia A., Funk, Janet L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594878/ https://www.ncbi.nlm.nih.gov/pubmed/34790880 http://dx.doi.org/10.20517/2394-4722.2021.27 |
Ejemplares similares
-
A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression
por: Cheng, Julia N., et al.
Publicado: (2021) -
Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer
por: Wu, Kerui, et al.
Publicado: (2021) -
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
por: Chiu, Jen-Hwey, et al.
Publicado: (2017) -
15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss
por: Kim, Ki Rim, et al.
Publicado: (2015) -
Association of adenosine signaling gene signature with estrogen receptor-positive breast and prostate cancer bone metastasis
por: Shropshire, Daniel Brian, et al.
Publicado: (2022)